DRIPCALC V2 LAUNCH SALE - 40% OFF

NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!

Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.

IRON | NASDAQ

$75.06 -$0.94 | -1.24%

TREND SIGNAL: Signal available — unlock to view

Signal available — unlock to view

|2026-10-21

Next Earnings: Nov 05, 2026

Add to favoritesFavorite

Company Overview:

Market Cap: $2.88B

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $40.00 - $99.50

6.2 Year IRON Performance Metrics:

Total Return (with DRIP): -75.7% (-20.41% CAGR)

Total Return (no DRIP): -75.7% (-20.41% CAGR)

Share Price: -75.7% (-20.41% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $2,429

Total Return $ (with DRIP): -$7,571

IRON Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

IRON Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $172.80/yr ($14.40/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 55% Lifetime Discount

ULTRA

$576 ($48/mo) $345.60/yr ($28.80/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 55% Lifetime Discount

IRON Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

IRON - Revenue

IRON Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - Earnings Per Share (EPS)

IRON EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - Net Income

🔓 See the full chart40% off right now · 7-day free trial

IRON Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - EBITDA

🔓 See the full chart40% off right now · 7-day free trial

IRON EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - Free Cash Flow

🔓 See the full chart40% off right now · 7-day free trial

IRON Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - Free Cash Flow / Share

🔓 See the full chart40% off right now · 7-day free trial

IRON Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - Operating Income

🔓 See the full chart40% off right now · 7-day free trial

IRON Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - Gross Profit

🔓 See the full chart40% off right now · 7-day free trial

IRON Gross Profit CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - Shares Outstanding

🔓 See the full chart40% off right now · 7-day free trial

IRON Shares Outstanding CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - Share Buybacks

🔓 See the full chart40% off right now · 7-day free trial

IRON Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - Stock-Based Comp

🔓 See the full chart40% off right now · 7-day free trial

IRON Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - Expenses

🔓 See the full chart40% off right now · 7-day free trial

IRON Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - Revenue vs Net Income

🔓 See the full chart40% off right now · 7-day free trial

IRON - EPS vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

IRON - EPS vs PE Ratio

🔓 See the full chart40% off right now · 7-day free trial

IRON - FCF vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

IRON - FCF vs Stock Based Comp

🔓 See the full chart40% off right now · 7-day free trial

IRON - Cash & Debt

🔓 See the full chart40% off right now · 7-day free trial

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

IRON - REVENUE: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

IRON Actual Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - EPS: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

IRON Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - NET INCOME: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

IRON Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - EBITDA: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

IRON Actual EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

IRON - Net Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

IRON Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - Gross Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

IRON Gross Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - Price to Earnings

🔓 See the full chart40% off right now · 7-day free trial

IRON Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - Price To Sales Ratio

🔓 See the full chart40% off right now · 7-day free trial

IRON Price To Sales Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - Return on Capital Employed

🔓 See the full chart40% off right now · 7-day free trial

IRON Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

IRON - Return on Invested Capital

🔓 See the full chart40% off right now · 7-day free trial

IRON Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Projected Future Returns & Dividends for IRON

Based on past 6.2-year performance, here are IRON growth metrics:

Share price CAGR of -20.41%
Dividend CAGR of +0%

Using IRON CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	IRON (DRIP)	IRON - No DRIP
Current Price	$75.06	$75.06
Start Shares	133.23	133.23
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	133.23	133.23
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$7.66	$75.06
Total Dividends	$0	$0
Final Value	$1,020	$10,000

Estimated Future Value + Dividends - IRON

NOTE: Above numbers are our estimate based on IRON's Dividend and Price CAGR over past 6.2 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $172.80/yr ($14.40/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 55% Lifetime Discount

ULTRA

$576 ($48/mo) $345.60/yr ($28.80/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 55% Lifetime Discount

Company Info

Disc Medicine, Inc. (IRON) had its IPO on , and is traded on NASDAQ stock exchange.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for serious hematologic diseases. The company’s work centers on red blood cell biology, with programs designed to address disorders involving heme biosynthesis and iron homeostasis. Its current pipeline includes therapies in development for rare blood diseases such as erythropoietic porphyrias, Diamond-Blackfan anemia, anemia associated with myelofibrosis, and polycythemia vera. Disc Medicine operates as a research-driven biotech business, advancing both clinical and preclinical candidates aimed at modifying fundamental biological pathways rather than offering broad commercial products. Headquartered in Watertown, Massachusetts, Disc Medicine plays a specialized role in the hematology market by concentrating on diseases with significant unmet medical need and limited treatment options.

IRON website: https://www.discmedicine.com

Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $172.80/yr ($14.40/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 55% Lifetime Discount

ULTRA

$576 ($48/mo) $345.60/yr ($28.80/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 55% Lifetime Discount

Loading signals…

DCF Model — IRON

Value from:

EPS (TTM)icompany profit per share over the last 12 months

EPS Growth %ihow fast profit per share grows each of the next 5 years — prefilled with what analysts expect

EPS growth after year 5 (forever)ithe slower pace once the fast 5 years are over — only drives years 6-10 of the price path below

Exit multiple (PE in 5 yrs)iwhat buyers pay per $1 of profit in 2031 — prefilled with today’s forward PE

Desired return %/yrithe yearly return you want from buying today — the S&P has done ~14%/yr, ask for more from a single stock

FCF growth %/yr (next 5 yrs)ihow fast free cash flow grows while the company is still expanding fast

Years of fast FCF growthihow many years the fast growth lasts before the business settles down

FCF growth after year 5 (forever)ithe slow, steady pace once the company is mature — usually 2-3%, near inflation. Must stay below your target return

Risk-free rate %iwhat a 10-yr US treasury pays with zero risk — the floor any risky stock must beat

Your target return %/yrithe yearly return you want for taking this risk — rule of thumb: risk-free rate + extra for risk

FCF base ($M, TTM)ilast 12 months of free cash flow, added up from reported quarters

Include dividends in returnidividends hand you part of the return in cash, so the share price needs to climb less

Pay up to today

—

vs current price $75.06

—

Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today

—

grows for the next years

Then mature

—

every future dollar counted back to today

Pile of today-dollars

—

÷ shares

Implied price path

Year	FCF	Implied price

Sensitivity — fair value: growth ↓ × target return →

× Free Portfolio Tracker

Own IRON? See every dividend it's paid you

Add your IRON shares to a free account and every payment you've received is listed — dated, in dollars — with reinvested shares counted and monthly totals. Room for 4 more stocks.

✓Every IRON dividend you've received, dated, with the amount
✓Reinvested (DRIP) shares counted for you
✓Monthly totals across up to 5 stocks

Add IRON free →

Free plan · up to 5 holdings